{"title":"Does the extent of the surgical margin affect the likelihood of local recurrence in Patnaik grade I or II cutaneous mast cell tumours?","authors":"Christos Dorlis","doi":"10.18849/ve.v7i1.508","DOIUrl":null,"url":null,"abstract":"PICO question \nDoes the extent of the surgical margin affect the likelihood of local recurrence in Patnaik grade I or II cutaneous mast cell tumours? \n \nClinical bottom line \nCategory of research question \nTreatment \nThe number and type of study designs reviewed \nEight papers were critically reviewed. Five were retrospective case series, two prospective clinical trials, and one prospective case series \nStrength of evidence \nLow \nOutcomes reported \nSequin et al. (2001) reported a local recurrence rate of 5%, but this study is 20 years old. In the studies of Simpson et al. (2004), Fulcher et al. (2006), Pratschke et al. (2013), Saunders et al. (2020), and Itoh et al. (2021), no local recurrence was observed in grade I and II mast cell tumours, while in the Milovancev et al. (2019) study, only 1/30 low-grade cutaneous mast cell tumors developed local recurrence. Therefore, there is some evidence that conservative surgical excision is sufficient to achieve local control with low recurrence rates \nConclusion \nThere is increasing evidence in the literature for conservative surgical excision of grade I and II MCTs, but because the quality of evidence is low, no clear recommendations can be made. Further studies are needed to determine recommendations for surgical excision of cutaneous MCTs based on the biological characteristics of the tumour and the completeness of histologic margins \n \nHow to apply this evidence in practice \nThe application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. \nKnowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care. \n \n","PeriodicalId":257905,"journal":{"name":"Veterinary Evidence","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary Evidence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18849/ve.v7i1.508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
PICO question
Does the extent of the surgical margin affect the likelihood of local recurrence in Patnaik grade I or II cutaneous mast cell tumours?
Clinical bottom line
Category of research question
Treatment
The number and type of study designs reviewed
Eight papers were critically reviewed. Five were retrospective case series, two prospective clinical trials, and one prospective case series
Strength of evidence
Low
Outcomes reported
Sequin et al. (2001) reported a local recurrence rate of 5%, but this study is 20 years old. In the studies of Simpson et al. (2004), Fulcher et al. (2006), Pratschke et al. (2013), Saunders et al. (2020), and Itoh et al. (2021), no local recurrence was observed in grade I and II mast cell tumours, while in the Milovancev et al. (2019) study, only 1/30 low-grade cutaneous mast cell tumors developed local recurrence. Therefore, there is some evidence that conservative surgical excision is sufficient to achieve local control with low recurrence rates
Conclusion
There is increasing evidence in the literature for conservative surgical excision of grade I and II MCTs, but because the quality of evidence is low, no clear recommendations can be made. Further studies are needed to determine recommendations for surgical excision of cutaneous MCTs based on the biological characteristics of the tumour and the completeness of histologic margins
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
PICO问题:手术切缘的范围是否影响帕特奈克I级或II级皮肤肥大细胞瘤局部复发的可能性?临床底线研究问题类别治疗研究设计的数量和类型审查了8篇论文。其中5项为回顾性病例系列,2项为前瞻性临床试验,1项为前瞻性病例系列。证据强度:低结局:Sequin et al.(2001)报道的局部复发率为5%,但该研究已有20年历史。在Simpson等人(2004)、Fulcher等人(2006)、Pratschke等人(2013)、Saunders等人(2020)、Itoh等人(2021)的研究中,I级和II级肥大细胞瘤未见局部复发,而在milovancevv等人(2019)的研究中,只有1/30的低级别皮肤肥大细胞瘤出现局部复发。因此,有证据表明保守性手术切除足以达到局部控制,复发率低。结论对于I级和II级mct保守性手术切除的文献证据越来越多,但由于证据质量较低,无法提出明确的建议。基于肿瘤的生物学特征和组织学边缘的完整性,需要进一步的研究来确定手术切除皮肤mct的建议。如何在实践中应用这些证据。证据在实践中的应用应考虑多种因素,不限于:个人的临床专业知识,病人的情况和业主的价值观,你工作的国家,地点或诊所,你面前的个案,治疗和资源的可用性。知识摘要是帮助加强或告知决策的资源。他们不会凌驾于从业者的责任或判断之上,去做对他们照顾的动物最好的事情。